A systematic review of 52 scientific papers submitted to a world-leading clinical genetics journal from multiple scientists ...

Independent clinical validation strengthens ABL’s leadership in the fast‑growing HIV drug‑resistance testing market ABL ...

TORONTO, March 05, 2026 (GLOBE NEWSWIRE) -- National Angel Capital Organization (NACO) today released Canada’s Funding Gaps, ...

Genome editing-based therapies typically aim to treat disease by correcting underlying genetic mutations in patient’s cells. However, most genetic disorders are caused by dozens or even thousands of ...

Researchers used molecular signatures in mobile DNA to trace the evolutionary origins of the cultivated strawberry genome.

An expected review of the United States' measles elimination status has been postponed by 7 months and will now take place in November.

Genome editing-based therapies typically aim to treat disease by correcting underlying genetic mutations in patient's cells. However, most genetic ...

Trained on 9 trillion DNA base pairs from every domain of life, the Evo 2 model can predict disease-causing mutations, identify genomic features and generate entirely new genetic sequences.

Illumina, Inc. (NASDAQ: ILMN) today announced new customer breakthroughs in oncology powered by Illumina's spatial transcriptomics, 5-base sequencing, and proteomics technologies. The ability to ...

Neurodegenerative diseases affect more than 57 million people globally. The incidence of these diseases, from Alzheimer's to Parkinson's to ALS and beyond, is expected to double every 20 years. Though ...